http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H05239080-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_66a9d6f86e9d9803174d2a03d3cd24a3 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-88 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-282 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 1991-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_263e071328d9cd1cb996f635762b3574 |
| publicationDate | 1993-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-H05239080-A |
| titleOfInvention | Novel platinum complex and antitumor agent containing the complex as an active ingredient |
| abstract | (57) [Summary] [Objective] The present invention has lower toxicity than conventional platinum complexes, The purpose is to provide a drug having a higher antitumor effect. [Structure] The present invention provides a novel platinum complex [diammine platinum-3,3-dimethylglutarimide blue] having a structure represented by the following formula, a pharmaceutically acceptable salt thereof and the complex and a pharmacologically It is an antitumor agent containing an acceptable salt as an active ingredient. |
| priorityDate | 1991-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 27.